Indications and uses
Controls and helps eliminate recurrence of: skin itching irritation redness flaking and scaling associated with psoriasis and seborrheic dermatitis.
Controls and helps eliminate recurrence of: skin itching irritation redness flaking and scaling associated with psoriasis and seborrheic dermatitis.
apply to affected areas one to four times daily or as directed by a doctor.
Store in a cool, dry place below 77°F Protect from heat and light
Salicylic Acid 2%
Psoriasis / Seborrheic Dermatitis
Controls and helps eliminate recurrence of:
|
For external use only.
If pregnant or breast feeding ask a doctor before
use.
Keep out of reach of children. If swallowed, get medical help or contact Poison Control Center immediately.
arnica montana flower, calendula officinalis flower, cannabis sativa seed oil, emulsifying wax, horse chestnut, imidazolidinyl urea, sheanut oil, spearmint oil, stearic acid, water
Manufactured for Electrolyzed Innovations, LLC (866) 528-3721 2214 Wilshire Dr, Piqua, OH 45356 USA |
Psoriasis and Seborrheic Dermatitis Formula
Soothion
Ion Dispersion Formula Designed to Relieve
Net Wt. 8 oz ( 226 g ) Made in USA
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69031-004-08 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-6b7d-a426-e053-dadaa90af4c2 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69031-004-08 | Soothion Psoriasis and Seborrheic Dermatitis Formula | 226 g in 1 BOTTLE | LOTION | 226 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| ARNICA MONTANA FLOWER | INACTIVE INGREDIENT | OZ0E5Y15PZ | 1 | |
| CALENDULA OFFICINALIS FLOWER | INACTIVE INGREDIENT | P0M7O4Y7YD | 1 | |
| CANNABIS SATIVA SEED OIL | INACTIVE INGREDIENT | 69VJ1LPN1S | 1 | |
| HORSE CHESTNUT | INACTIVE INGREDIENT | 3C18L6RJAZ | 1 | |
| IMIDUREA | INACTIVE INGREDIENT | M629807ATL | 1 | |
| SHEANUT OIL | INACTIVE INGREDIENT | O88E196QRF | 1 | |
| SPEARMINT OIL | INACTIVE INGREDIENT | C3M81465G5 | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69031-004 | 69031-004-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARNICA MONTANA FLOWER | OZ0E5Y15PZ | IACT |
| CALENDULA OFFICINALIS FLOWER | P0M7O4Y7YD | IACT |
| CANNABIS SATIVA SEED OIL | 69VJ1LPN1S | IACT |
| HORSE CHESTNUT | 3C18L6RJAZ | IACT |
| IMIDUREA | M629807ATL | IACT |
| SHEANUT OIL | O88E196QRF | IACT |
| SPEARMINT OIL | C3M81465G5 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| WATER | 059QF0KO0R | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 360 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| IMIDUREA | IMIDUREA | M629807ATL | LOTION / TOPICAL | 228 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| SPEARMINT OIL | SPEARMINT OIL | C3M81465G5 | SYRUP / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| SPEARMINT OIL | SPEARMINT OIL | C3M81465G5 | TABLET / SUBLINGUAL | 0.4 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| SPEARMINT OIL | SPEARMINT OIL | C3M81465G5 | CAPSULE / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 70 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| SPEARMINT OIL | SPEARMINT OIL | C3M81465G5 | SUSPENSION / ORAL | 0.59 mg/20ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| IMIDUREA | IMIDUREA | M629807ATL | SHAMPOO / TOPICAL | 120 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| SPEARMINT OIL | SPEARMINT OIL | C3M81465G5 | OINTMENT / TOPICAL | NA | ||
| SPEARMINT OIL | SPEARMINT OIL | C3M81465G5 | PASTE, DENTIFRICE / DENTAL | 27.6 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| IMIDUREA | IMIDUREA | M629807ATL | CREAM / TOPICAL | 0.4 %w/w | ||
| SPEARMINT OIL | SPEARMINT OIL | C3M81465G5 | SOLUTION / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9a66542f-9dc4-2f00-e053-2995a90ac130 | b64d3b37-4242-4779-9a47-957b04ff384d | 2019-12-23 | Warnings | 9a66542f-9dc4-2f00-e053-2995a90ac130 b64d3b37-4242-4779-9a47-957b04ff384d |
Adverse event summaries are temporarily unavailable. Other product information remains available.